Jia Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jia Xie has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Fajin Lv
Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
1 shared publication - Jiayi Pu
Department of Radiology, The First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China
1 shared publication - Miao Wei
Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
1 shared publication - Wen Li
Medical Imaging Department, Yubei District Traditional Chinese Medicine Hospital, Chongqing 401120, China
1 shared publication - Wenqin Zhou
Department of Radiology, The First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China
1 shared publication - Yan Xiao
Department of Radiology, Bishan Hospital of Chongqing Medical University, Chongqing 420760, China
1 shared publication
Latest Publications
- Open Access
- 8 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 512
Opportunistic Osteoporosis Screening in Breast Cancer Using AI-Derived Vertebral BMD from Routine CT: Validation Against QCT and Multivariable Diagnostic Modeling
Background/Objectives: Breast cancer survivors face elevated risk of treatment-related bone loss, yet routine bone health assessment remains underutilized. Opportunistic bone density extraction from routine CT may address this gap. This study validated AI-derived vertebral bone mineral density (AI-vBMD) from non-contrast thoracoabdominal CT for osteoporosis screening and assessed its diagnostic value beyond clinical variables. Methods: This retrospective study included 332 breast cancer patients; AI-vBMD was successfully extracted in 325 (98%). Quantitative CT (QCT) served as reference standard. Agreement between AI-vBMD and QCT-vBMD was assessed using Pearson correlation, Bland–Altman analysis, and weighted kappa for QCT-defined osteoporosis (3). Nested logistic regression models compared a clinical model with and without AI-vBMD. Discrimination [area under the curve (AUC)], calibration, and clinical utility [decision-curve analysis (DCA)] were evaluated. Results: AI-vBMD showed strong correlation with QCT-vBMD (r = 0.98, p < 0.001), minimal bias (mean difference +1.82 mg/cm3), and excellent agreement for osteoporosis classification (weighted κ = 0.90). AI-vBMD alone achieved excellent discrimination for osteoporosis (AUC = 0.986). Integrating AI-vBMD into the clinical model yielded significantly higher diagnostic performance (AUC 0.988 vs. 0.879; p < 0.001) and demonstrated superior net benefit across relevant decision thresholds. Conclusions: AI-derived vertebral BMD from routine CT serves as a reliable QCT-aligned imaging biomarker for opportunistic osteoporosis assessment in breast cancer patients and adds significant incremental diagnostic value beyond clinical information alone.
- 8 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 512
Open AccessOpportunistic Osteoporosis Screening in Breast Cancer Using AI-Derived Vertebral BMD from Routine CT: Validation Against QCT and Multivariable Diagnostic Modeling
Background/Objectives: Breast cancer survivors face elevated risk of treatment-related bone loss, yet routine bone health assessment remains underutilized. Opportunistic bone density extraction from routine CT may address this gap. This study validated AI-derived vertebral bone mineral density (AI-vBMD) from non-contrast thoracoabdominal CT for osteoporosis screening and assessed its diagnostic value beyond clinical variables. Methods: This retrospective study included 332 breast cancer patients; AI-vBMD was successfully extracted in 325 (98%). Quantitative CT (QCT) served as reference standard. Agreement between AI-vBMD and QCT-vBMD was assessed using Pearson correlation, Bland–Altman analysis, and weighted kappa for QCT-defined osteoporosis (3). Nested logistic regression models compared a clinical model with and without AI-vBMD. Discrimination [area under the curve (AUC)], calibration, and clinical utility [decision-curve analysis (DCA)] were evaluated. Results: AI-vBMD showed strong correlation with QCT-vBMD (r = 0.98, p < 0.001), minimal bias (mean difference +1.82 mg/cm3), and excellent agreement for osteoporosis classification (weighted κ = 0.90). AI-vBMD alone achieved excellent discrimination for osteoporosis (AUC = 0.986). Integrating AI-vBMD into the clinical model yielded significantly higher diagnostic performance (AUC 0.988 vs. 0.879; p < 0.001) and demonstrated superior net benefit across relevant decision thresholds. Conclusions: AI-derived vertebral BMD from routine CT serves as a reliable QCT-aligned imaging biomarker for opportunistic osteoporosis assessment in breast cancer patients and adds significant incremental diagnostic value beyond clinical information alone.